Navigation Links
Using waste to recover waste uranium
Date:9/6/2009

Using bacteria and inositol phosphate, a chemical analogue of a cheap waste material from plants, researchers at Birmingham University have recovered uranium from the polluted waters from uranium mines. The same technology can also be used to clean up nuclear waste. Professor Lynne Macaskie, this week (7-10 September), presented the group's work to the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh.

Bacteria, in this case, E. coli, break down a source of inositol phosphate (also called phytic acid), a phosphate storage material in seeds, to free the phosphate molecules. The phosphate then binds to the uranium forming a uranium phosphate precipitate on the bacterial cells that can be harvested to recover the uranium.

This process was first described in 1995, but then a more expensive additive was used and that, combined with the then low price of uranium, made the process uneconomic. The discovery that inositol phosphate was potentially six times more effective as well as being a cheap waste material means that the process becomes economically viable, especially as the world price of uranium is likely to increase as countries move to expand their nuclear technologies in a bid to produce low-carbon energy.

As an example, if pure inositol phosphate, bought from a commercial supplier is used, the cost of this process is 1.72 per gram of uranium recovered. If a cheaper source of inositol phosphate is used (eg calcium phytate) the cost reduces to 0.09 for each gram of recovered uranium. At 2007 prices, uranium cost 0.211/g; it is currently 0.09/g. These prices make the process economic overall because there is also an environmental protection benefit. Use of low-grade inositol phosphate from agricultural wastes would bring the cost down still further and the economic benefit will also increase as the price of uranium is forecast to rise again.

"The UK has no natural uranium reserves, although a significant amount of uranium is produced in nuclear wastes. There is no global shortage of uranium but from the point of view of energy security the EU needs to be able to recover as much uranium as possible from mine run-offs (which in any case pollute the environment) as well as recycling as much uranium as possible from nuclear wastes," commented Professor Macaskie, "By using a cheap feedstock easily obtained from plant wastes we have shown that an economic, scalable process for uranium recovery is possible".


'/>"/>

Contact: Dianne Stilwell
diannestilwell@me.com
44-795-720-0214
Society for General Microbiology
Source:Eurekalert

Related biology technology :

1. New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene-Editing Technology
2. The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method
3. Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
4. Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
5. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
6. Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage
7. First step to converting solar energy using artificial leaf
8. Providence Health & Services Increases Revenue by $35 Million Using Concuity ClearContracts
9. Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology
10. CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology
11. EClips Energy Technologies, Inc. To Develop New Sterile Air Product Using PATI Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Tenn. , Feb. 24, 2017 ... ("Provectus" or the "Company"), a clinical-stage oncology and ... regarding the deadline to participate in its previously ... units, consisting of shares of common stock and ... and holders of listed warrants. ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  OncoSec Medical ... cancer immunotherapies, will host a Key Opinion Leader event ... as an oral and poster presentation at the upcoming ... plan. The KOL event will be held in-person and ... PM EST / 9:00 AM PST at the Lotte ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
Breaking Biology Technology:
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/25/2017)... YORK , Jan. 25, 2017 The ... Access Management (IAM) lifecycle is comprised of a ... for the purpose of maintaining digital identities and ... resources and applications. There are significant number of ... from time to time by optimizing processes and ...
Breaking Biology News(10 mins):